P&G Hygiene and Health Care has announced a crucial board meeting scheduled for May 28, 2026, where directors will review the company's annual financial performance and consider dividend distribution to shareholders. The meeting represents a key milestone in the company's corporate calendar as it marks the formal approval of year-end financial results.

Board Meeting Agenda and Key Decisions

The board meeting has been convened primarily to address two critical corporate matters that directly impact shareholders and stakeholders. The directors will focus on reviewing the company's financial performance for the completed fiscal year and making important decisions regarding shareholder returns.

Financial Statements Review Process

The primary agenda item involves the consideration and approval of audited financial statements for the financial year ending March 31, 2026. This process represents the culmination of the company's annual financial reporting cycle, where the board will examine the comprehensive financial performance, including revenue, profitability, and overall business health. The audited statements provide stakeholders with verified financial information that has undergone rigorous external scrutiny.

Dividend Deliberations

Alongside the financial statements approval, the board will consider the recommendation of a final dividend for shareholders. This decision reflects the company's commitment to sharing profits with its investor base and demonstrates confidence in its financial position. The final dividend consideration follows standard corporate practices where companies evaluate their cash flows, future capital requirements, and overall financial health before making distribution decisions.

Regulatory Compliance and Transparency

The announcement was made in strict compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory framework ensures that listed companies maintain transparency with their stakeholders by providing advance notice of significant board meetings. The company has fulfilled its obligation to inform both the BSE Limited and the National Stock Exchange of India Limited about the scheduled meeting, demonstrating adherence to corporate governance standards.

Corporate Communication Framework

Procter & Gamble Hygiene and Health Care Limited has maintained its commitment to transparent communication with regulatory authorities and shareholders. The formal notification was signed by Flavia Machado, an authorized signatory, and submitted to both major stock exchanges where the company's shares are listed. This systematic approach to corporate communication ensures that all stakeholders receive timely information about significant corporate developments that may impact their investment decisions.

P&G Hygiene and Health Care Limited has announced a significant executive role transition, informing stock exchanges about changes in its senior management structure. The company has communicated this development to both BSE Limited and National Stock Exchange of India Limited under SEBI regulatory requirements.

Executive Role Transition Details

The company has announced that Mr. Ghanashyam Hegde will be transitioning from his current role to a broader regional position within the Procter & Gamble organization. This change represents an expansion of responsibilities across multiple markets.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to disclose material events and information that could impact investor decisions, including changes in key managerial personnel.

The communication was formally addressed to both major Indian stock exchanges where the company's shares are listed. The company trades under scrip code 500459 on BSE Limited and symbol PGHH on the National Stock Exchange of India Limited.

Company Information

Procter & Gamble Hygiene and Health Care Limited operates from its registered office at P&G Plaza, Cardinal Gracias Road, Chakala, Andheri (E), Mumbai. The company, incorporated in 1964, holds CIN L24239MH1964PLC012971 and maintains its corporate website at in.pg.com.

The official communication was signed by Flavia Machado as the authorized signatory, ensuring proper corporate governance protocols were followed in making this announcement to the investment community and regulatory authorities.